MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function
- PMID: 16830130
- DOI: 10.1007/s00213-006-0434-z
MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function
Abstract
Rationale: The party drug ecstasy is frequently used in combination with other drugs like marihuana and alcohol. In addition, a substantial proportion of the MDMA users has claimed to drive a car when under the influence of MDMA and/or other drugs.
Objective: To assess the effects of MDMA and alcohol, combined and alone, on actual driving performance and laboratory tasks related to driving.
Methods: Eighteen healthy subjects participated in a double-blind, placebo-controlled, six-way cross-over study. Treatments consisted of MDMA 0, 75, and 100 mg with and without alcohol, aiming at 0.06 mg/ml BAC. Laboratory tests (critical tracking task, object movement estimation task) were conducted between 1.5 and 2 h postdrug (0.5 and 1 h postalcohol). Actual driving tests (road tracking test, car-following test) were conducted between 3 and 5 h postdrug (2 and 4 h postalcohol). Subjects completed the addiction research center inventory (ARCI) and rated their driving quality and mental effort during driving.
Results: Alcohol alone impaired critical tracking performance, as well as a number of actual driving performance parameters [i.e., standard deviation of lateral position (SDLP), brake reaction time, and coherence]. MDMA alone reduced SDLP and standard deviation of speed. MDMA significantly moderated alcohol induced impairment of road tracking performance but did not affect alcohol impairments of car-following and laboratory task performance. Subjective data seemed to support objective data.
Conclusion: MDMA moderated the impairing effects of a low dose of alcohol on road tracking performance but it could not overcome alcohol-induced impairment on other aspects of driving behavior or driving related performance.
Similar articles
-
Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.Addiction. 2006 Nov;101(11):1614-21. doi: 10.1111/j.1360-0443.2006.01566.x. Addiction. 2006. PMID: 17034441 Clinical Trial.
-
Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.J Psychopharmacol. 2003 Dec;17(4):379-87. doi: 10.1177/0269881103174015. J Psychopharmacol. 2003. PMID: 14870949 Clinical Trial.
-
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.Neuropsychopharmacology. 2006 May;31(5):1048-55. doi: 10.1038/sj.npp.1300894. Neuropsychopharmacology. 2006. PMID: 16160704 Clinical Trial.
-
Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.J Clin Psychiatry. 2003 Jan;64(1):20-9. J Clin Psychiatry. 2003. PMID: 12590619 Review.
-
The sensitivity of laboratory tests assessing driving related skills to dose-related impairment of alcohol: A literature review.Accid Anal Prev. 2016 Apr;89:31-48. doi: 10.1016/j.aap.2016.01.001. Epub 2016 Jan 20. Accid Anal Prev. 2016. PMID: 26802474 Review.
Cited by
-
Long-term effects of daylight saving time on driving fatigue.Heliyon. 2024 Jul 20;10(15):e34956. doi: 10.1016/j.heliyon.2024.e34956. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39145016 Free PMC article.
-
Blockade of 5-HT2 receptor selectively prevents MDMA-induced verbal memory impairment.Neuropsychopharmacology. 2011 Aug;36(9):1932-9. doi: 10.1038/npp.2011.80. Epub 2011 May 11. Neuropsychopharmacology. 2011. PMID: 21562484 Free PMC article. Clinical Trial.
-
An updated survey on the recent advancement of antimalarial molecules: synthetic methodologies and SAR studies.Mol Divers. 2025 Mar 28. doi: 10.1007/s11030-025-11143-4. Online ahead of print. Mol Divers. 2025. PMID: 40153157 Review.
-
Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night.Psychopharmacology (Berl). 2007 May;192(1):111-9. doi: 10.1007/s00213-006-0679-6. Epub 2007 Jan 12. Psychopharmacology (Berl). 2007. PMID: 17219216 Clinical Trial.
-
The prevalence of substance use among drivers with traffic injuries in Mazandaran Province, Northern Iran.Ann Med Surg (Lond). 2022 Sep 27;82:104768. doi: 10.1016/j.amsu.2022.104768. eCollection 2022 Oct. Ann Med Surg (Lond). 2022. PMID: 36268435 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical